Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Activepassive International Equity ETF (APIE)

Activepassive International Equity ETF (APIE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Novo Nordisk Warns Against Counterfeit Ozempic In US: Retail’s Unmoved

The company said the seized counterfeit products feature lot number PAR0362 and illegitimate serial numbers beginning with the first eight digits, 51746517.

APIE : 38.47 (+0.29%)
NVO : 49.12 (-0.51%)
AVDE : 90.69 (+0.29%)
Novo Nordisk’s Controlling Shareholder Novo Holdings Reports Record Total Income, Investment Returns In 2024: Retail Stays Bullish

The company said that its earnings consist of income from dividends and the share repurchase programmes of Novo Group companies Novo Nordisk A/S and Novonesis A/S, as well as returns from its investment...

APIE : 38.47 (+0.29%)
NVO : 49.12 (-0.51%)
AVDE : 90.69 (+0.29%)
Novo Nordisk Signs $2B Deal For Obesity Drug With Chinese Biotech: Retail Sentiment Improves

Novo Nordisk will obtain exclusive worldwide rights to develop, manufacture, and commercialize the drug UBT251, while United Biotechnology will, however, retain the rights to the drug in mainland China,...

APIE : 38.47 (+0.29%)
NVO : 49.12 (-0.51%)
AVDE : 90.69 (+0.29%)
Sony Stock Surges After Q3 Earnings Beat, Raised Outlook: Retail’s Not Convinced

For full-year 2024, Sony expects revenue to be about JPY 13.2 trillion ($876 billion), 4% higher than its previous outlook.

SONY : 22.83 (+2.24%)
APIE : 38.47 (+0.29%)
AVDE : 90.69 (+0.29%)
Toyota Downgraded After Second Straight Profit Drop, But Stock Climbs As Annual Outlook Improves: Retail Stays Optimistic

Toyota also announced plans to establish a wholly owned company in Shanghai to develop and produce Lexus BEVs and batteries.

FVD : 49.26 (+0.65%)
APIE : 38.47 (+0.29%)
AVDE : 90.69 (+0.29%)
TM : 238.24 (-1.71%)
Adidas Stock In Focus On Reported Layoffs: Retail's On The Sidelines

Adidas shares have increased 5% over the past five days after the footwear and sports apparel maker reported strong preliminary Q4 earnings

ADDYY : 92.5900 (+0.96%)
APIE : 38.47 (+0.29%)
Toyota Stock Catches Retail's Eye After Report Of Auto Giant's Aim To Double Equity Returns

The news boosted Toyota’s shares by nearly 6% in Tokyo trading earlier in the day.

FVD : 49.26 (+0.65%)
APIE : 38.47 (+0.29%)
AVDE : 90.69 (+0.29%)
TM : 238.24 (-1.71%)
Sony Stock Jumps Pre-Market As Profit Booms Nearly 70%: Retail Buzz Builds

Despite selling only 3.8 million PlayStation 5 units this quarter — down from 4.9 million a year ago — Sony raised its annual profit forecast.

SONY : 22.83 (+2.24%)
APIE : 38.47 (+0.29%)
AVDE : 90.69 (+0.29%)
AVIV : 78.87 (+0.08%)

Barchart Exclusives

This Is the Top-Rated Dividend Stock to Buy in February 2026
CMCL’s low payout ratio, hedged $3,500‑floor gold pricing, and 56% implied upside from its lone “Strong Buy” target make it an attractive small‑cap dividend grower for 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar